Browse studies, page 387
Page 387 of 1,298, newest first. Search them all at once, ranked by relevance, in Evidence Hub.
- Recent progress in small molecules targeting the acidic tumor microenvironment Journal of enzyme inhibition and medicinal chemistry, 2026
- Analytical Methods Developed for the Determination of Pantoprazole Sodium: Overview Critical reviews in analytical chemistry, 2026
- High Economic Burden Yet Low Clinical Value: Why Is so Much Sucralfate Prescribed? Basic & clinical pharmacology & toxicology, 2025
- Vonoprazan: A Review in Erosive Esophagitis and Non-Erosive Gastro-Esophageal Reflux Disease Drugs, 2025
- A Comprehensive Analysis of Therapeutic Potential of Medicinal Plant Extracts to Treat Ethanol-Induced Gastric Ulcer Biomedicines, 2026
- Encapsulation-based enhancements in modern drug delivery systems International journal of pharmaceutics, 2026
- Leveraging Healthy Volunteers for Anticancer Drug Clinical Pharmacology Studies: A Review Article Featuring Futibatinib as an Example Clinical and translational science, 2026
- Association Between Gastroesophageal Reflux Disease and Frequency of Asthma Exacerbations: A Systematic Review and Meta-Analysis Cureus, 2026
- Rabeprazole: the role of proton pump inhibitors in Helicobacter pylori eradication Expert review of anti-infective therapy, 2005
- Proton pump inhibitors and acid-related diseases Pharmacotherapy, 1997
- Safety profile of the proton-pump inhibitors American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 1999
- Review of esomeprazole in the treatment of acid disorders Expert opinion on pharmacotherapy, 2003
- A Narrative Review on Efficacy and Safety of Proton Pump Inhibitors in Children Frontiers in pharmacology, 2022
- Why the Vonoprazan Helicobacter pylori Therapies in the US-European Trial Produced Unacceptable Cure Rates Digestive diseases and sciences, 2023
- Lansoprazole for maintenance of remission of erosive oesophagitis Drugs, 2002
- Gastro-duodenal protection in an era of cyclo-oxygenase-2-selective nonsteroidal anti-inflammatory drugs European journal of gastroenterology & hepatology, 2001
- Helicobacter pylori infection, chronic gastritis, and proton pump inhibitors Journal of clinical gastroenterology, 1998
- Evaluation of omeprazole, lansoprazole, pantoprazole, and rabeprazole in the treatment of acid-related diseases Journal of the American Pharmaceutical Association (Washington, D.C. : 1996), 2000
- Esomeprazole: a review of its use in the management of acid-related disorders Drugs, 2002
- What is potent acid inhibition, and how can it be achieved? Drugs, 2005
- Night-time gastro-oesophageal reflux disease: prevalence, hazards, and management European journal of gastroenterology & hepatology, 2005
- Delayed-release lansoprazole plus naproxen Drugs, 2004
- Global Warming and Prescribing: A Review on Medicines' Effects and Precautions Psychiatria Danubina, 2022
- Old Drugs and New Targets as an Outlook for the Treatment of Tuberculosis Current medicinal chemistry, 2018
- Improving health-related quality of life in gastro-oesophageal reflux disease Drugs, 2003
- Discovery of lansoprazole and its unique pharmacological properties independent from anti-secretory activity Current pharmaceutical design, 2013
- Helicobacter pylori: Perturbation and restoration of gut microbiome Journal of biosciences, 2020
- System-wide approaches to antimicrobial therapy and antimicrobial resistance in the UK: the AMR-X framework The Lancet. Microbe, 2024
- Stereoselective Pharmacodynamics and Pharmacokinetics of Proton Pump Inhibitors Current drug metabolism, 2016
- The pharmacology and clinical relevance of proton pump inhibitors Current gastroenterology reports, 2002
- An overview of the pharmacology, efficacy, safety and cost-effectiveness of lansoprazole International journal of clinical practice, 2002
- Review article: epidemiology and management of gastro-oesophageal reflux in children Alimentary pharmacology & therapeutics, 2004
- Practical considerations in the management of proton-pump inhibitors Revista espanola de enfermedades digestivas, 2016
- Pharmacogenomics of proton pump inhibitors Pharmacogenomics, 2004
- Gastroesophageal reflux disease during pregnancy Gastroenterology clinics of North America, 2003
- Future prospects for proton pump inhibitors Alimentary pharmacology & therapeutics, 1993
- Proton pump inhibitors may reduce tumour resistance Expert opinion on pharmacotherapy, 2005
- Characteristics of the Novel Potassium-Competitive Acid Blocker Vonoprazan Fumarate (TAK-438) Advances in therapy, 2016
- Tuberculosis: Past, present and future of the treatment and drug discovery research Current research in pharmacology and drug discovery, 2021
- Stereoselective disposition of proton pump inhibitors Clinical drug investigation, 2008
- Safety of proton pump inhibitors--an overview Alimentary pharmacology & therapeutics, 1994
- Potassium-competitive acid blockers and acid-related disorders Current opinion in endocrinology, diabetes, and obesity, 2024
- Gastric acid secretion: activation and inhibition The Yale journal of biology and medicine, 1994
- Safety of the long-term use of proton pump inhibitors World journal of gastroenterology, 2010
- Refractory gastroesophageal reflux disease Arquivos de gastroenterologia, 2012
- Pharmacotherapy for microscopic colitis Pharmacotherapy, 2007
- Review article: the pharmacology of rabeprazole Alimentary pharmacology & therapeutics, 1999
- Safety of proton pump inhibitors Medicina clinica, 2006
- Pharmacotherapy for acid/peptic disorders The Yale journal of biology and medicine, 1996
- Reflux esophagitis Nihon rinsho. Japanese journal of clinical medicine, 2002
- Barrett's oesophagus Postgraduate medical journal, 1998
- Microscopic colitis World journal of gastroenterology, 2012
- The First-in-Class Potassium-Competitive Acid Blocker, Vonoprazan Fumarate: Pharmacokinetic and Pharmacodynamic Considerations Clinical pharmacokinetics, 2016
- Diagnosis of Zollinger-Ellison syndrome: increasingly difficult World journal of gastroenterology, 2012
- The links between sleep duration, obesity and type 2 diabetes mellitus The Journal of endocrinology, 2021
- Peptic Ulcer Disease: A Review JAMA, 2024
- The Proton Pump Inhibitor Lansoprazole Has Hepatoprotective Effects in In Vitro and In Vivo Rat Models of Acute Liver Injury Digestive Diseases and Sciences, 2019
- Lansoprazole enhances the antidiabetic effect of dapagliflozin in fortified diet-fed streptozotocin-treated diabetic rats Journal of biochemical and molecular toxicology, 2020
- Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for HLA Genotype and Use of Carbamazepine and Oxcarbazepine: 2017 Update Clinical pharmacology and therapy, 2018
- Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 Genotype and Atomoxetine Therapy Clinical pharmacology and therapy, 2019
- Clinical Pharmacogenetics Implementation Consortium (CPIC®) Guideline for CYP2C19 and Voriconazole Therapy Clinical pharmacology and therapy, 2017
- AGREE II: advancing guideline development, reporting and evaluation in health care Canadian Medical Association Journal, 2010
- Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and Tamoxifen Therapy Clinical pharmacology and therapy, 2018
- An electrochemical sensor based on an Eriochrome Black T polymer and deep eutectic solvent for the simultaneous determination of omeprazole and lansoprazole Analytical Methods, 2020
- Macrolide antibiotics enhance the antitumor effect of lansoprazole resulting in lysosomal membrane permeabilization-associated cell death International Journal of Oncology, 2020
- Evaluation of [18F]N-methyl-lansoprazole as a tau PET imaging agent in first-in-human studies ACS Chemical Neuroscience, 2020
- Lansoprazole Alone or in Combination With Gefitinib Shows Antitumor Activity Against Non-small Cell Lung Cancer A549 Cells in vitro and in vivo Frontiers in Cell and Developmental Biology, 2021
- Barriers and Strategies in Guideline Implementation—A Scoping Review Healthcare, 2016
- Repositioning of Lansoprazole as a Protective Agent Against Cisplatin-Induced Ototoxicity Frontiers in Pharmacology, 2022
- ESPEN guideline on home enteral nutrition Clinical Nutrition, 2020
- Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Pharmacogenetics-Guided Warfarin dosing: 2017 Update Clinical pharmacology and therapy, 2017
- ESHRE guideline: recurrent pregnancy loss Human Reproduction Open, 2018
- Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents Pediatrics, 2017
- Method Validation of Esomeprazole Analysis in Human Plasma using High Performance Liquid Chromatography–Photodiode Array 2017
- RP-HPLC Method Development and Validation for the Estimation of Lansoprazole in Presence of Related Substances by QbD Approach Journal of Pharmaceutical Research International, 2021
- Method Development and Validation for Quantification of Potential Genotoxic Impurity, PyCl in Lansoprazole Hydrochloride using Liquid Chromatography Combined with Mass Spectrometry Asian Journal of Chemistry, 2021
- Development and validation of a RP-hplc method for the simultaneous estimation of clarithromycin, tinidazole and lansoprazole in fixed dose combinations Tropical journal of pharmaceutical and life sciences, 2021
- Guidelines on appropriate indications for upper gastrointestinal endoscopy. Working Party of the Joint Committee of the Royal College of Physicians of London, Royal College of Surgeons of England, Royal College of Anaesthetists, Association of Surgeons, the British Society of Gastroenterology, and the Thoracic Society of Great Britain BMJ (Clinical research ed.), 1995
- Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report. European Helicobacter Pylori Study Group Gut, 1997
- Guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacement Thyroid : official journal of the American Thyroid Association, 2014
- An evidence-based approach to the management of uninvestigated dyspepsia in the era of Helicobacter pylori. Canadian Dyspepsia Working Group CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2000
- Revised consensus statement on the preventive and symptomatic care of patients with leukodystrophies Molecular genetics and metabolism, 2017
- NANETS treatment guidelines: well-differentiated neuroendocrine tumors of the stomach and pancreas Pancreas, 2010
- QT interval screening in methadone maintenance treatment: report of a SAMHSA expert panel Journal of addictive diseases, 2011
- Proton pump inhibitor-responsive oesophageal eosinophilia: an entity challenging current diagnostic criteria for eosinophilic oesophagitis Gut, 2016
- Helicobacter pylori and gastroduodenal ulcer disease Deutsches Arzteblatt international, 2009
- Individualized Medication of Voriconazole: A Practice Guideline of the Division of Therapeutic Drug Monitoring, Chinese Pharmacological Society Therapeutic drug monitoring, 2018
- Pediatric Gastroesophageal Reflux Clinical Practice Guidelines: Joint Recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition Journal of pediatric gastroenterology and nutrition, 2018
- The Safety of Appropriate Use of Over-the-Counter Proton Pump Inhibitors: An Evidence-Based Review and Delphi Consensus Drugs, 2017
- The updated JSPGHAN guidelines for the management of Helicobacter pylori infection in childhood Pediatrics international : official journal of the Japan Pediatric Society, 2020
- Clinical Guidelines for Drug-induced Peptic Ulcer, 2020 Revised Edition The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, 2020
- Chronic Cough Due to Gastroesophageal Reflux in Adults: CHEST Guideline and Expert Panel Report Chest, 2016
- Evidence-based clinical practice guidelines for functional dyspepsia 2021 Journal of gastroenterology, 2022
- Sociedade Portuguesa de Cuidados Intensivos guidelines for stress ulcer prophylaxis in the intensive care unit Revista Brasileira de terapia intensiva, 2019
- Chronic Cough and Gastroesophageal Reflux in Children: CHEST Guideline and Expert Panel Report Chest, 2019
- American Association of Clinical Endocrinology Consensus Statement on Management of Multiple Endocrine Neoplasia Type 1 Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 2025
- Recommendations for Stress Ulcer Prophylaxis in Critically Ill Adults: A Contextualized Clinical Practice Guideline From the Saudi Critical Care Society and the Scandinavian Society of Anaesthesiology and Intensive Care Medicine, Endorsed by the Kuwait Anesthesia and Critical Care Society Acta anaesthesiologica Scandinavica, 2026
- Guideline for Medication Management of Distressing Symptoms in Older Patients Receiving End-of-Life Palliative Care Journal of evidence-based medicine, 2026
- Canadian Helicobacter pylori Consensus Conference update: infections in adults. Canadian Helicobacter Study Group Canadian journal of gastroenterology = Journal canadien de gastroenterologie, 1999
- Reversible opacification of a hydrophobic acrylic intraocular lens Journal of cataract and refractive surgery, 2020
